Stock Price
1,426.30
Daily Change
-10.40 -0.72%
Monthly
15.91%
Yearly
-4.91%
Q2 Forecast
1,316.96

Cipla reported INR6.86 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q4 Mar/2026 6.86 10.94 15.10 May/13
FY2026Q3 Dec/2025 11.20 14.92 19.43 Jan/23
FY2026Q1 Sep/2025 16.72 15.33 16.12 Oct/29
FY2026Q1 Jun/2025 16.06 14.87 14.57 Jul/25
FY2025Q4 Mar/2025 15.10 12.29 11.62 May/12




Eps Change Date
Arca Biopharma USD -0.54 0.14 Dec/2025
aTyr Pharma USD 0.53 0.8 Dec/2025
Bio Path USD -0.07 0.48 Sep/2025
Brainstorm Cell Therapeutics USD -0.19 0.15 Sep/2025
Capricor Therapeutics USD -0.62 0.08 Dec/2025
Cara Therapeutics USD -0.59 4.45 Sep/2025
Cipla INR 6.86 8.34 Mar/2026
Dr.Reddys Laboratories INR 5.8 8.72 Mar/2026
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Immunic USD -0.1 0.03 Dec/2025
Infinity Pharmaceuticals USD -0.11 0.01 Jun/2023
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sun Pharmaceuticals INR 12.8 0.2 Dec/2025
TherapeuticsMD USD -0.09 0.02 Jun/2024
UPL INR 12.57 7.88 Mar/2026